These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35978536)

  • 1. Mitochondria as a key player in systemic lupus erythematosus.
    Quintero-González DC; Muñoz-Urbano M; Vásquez G
    Autoimmunity; 2022 Dec; 55(8):497-505. PubMed ID: 35978536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial Dysfunction in Systemic Lupus Erythematosus with a Focus on Lupus Nephritis.
    Halfon M; Tankeu AT; Ribi C
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria in the Pathogenesis of Systemic Lupus Erythematosus.
    Chen PM; Tsokos GC
    Curr Rheumatol Rep; 2022 Apr; 24(4):88-95. PubMed ID: 35290598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging views of mitophagy in immunity and autoimmune diseases.
    Xu Y; Shen J; Ran Z
    Autophagy; 2020 Jan; 16(1):3-17. PubMed ID: 30951392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial impairment and repair in the pathogenesis of systemic lupus erythematosus.
    Zhao L; Hu X; Xiao F; Zhang X; Zhao L; Wang M
    Front Immunol; 2022; 13():929520. PubMed ID: 35958572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-DNA at the Epicenter of SLE: Immunogenic Forms, Regulation, and Effects.
    Soni C; Reizis B
    Front Immunol; 2019; 10():1601. PubMed ID: 31354738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Mitochondria in Systemic Lupus Erythematosus: A Glimpse of Various Pathogenetic Mechanisms.
    Yang SK; Zhang HR; Shi SP; Zhu YQ; Song N; Dai Q; Zhang W; Gui M; Zhang H
    Curr Med Chem; 2020; 27(20):3346-3361. PubMed ID: 30479205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal Mitochondrial Physiology in the Pathogenesis of Systemic Lupus Erythematosus.
    Wincup C; Radziszewska A
    Rheum Dis Clin North Am; 2021 Aug; 47(3):427-439. PubMed ID: 34215372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial Nucleic Acid as a Driver of Pathogenic Type I Interferon Induction in Mendelian Disease.
    Lepelley A; Wai T; Crow YJ
    Front Immunol; 2021; 12():729763. PubMed ID: 34512665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenesis of systemic lupus erythematosus - From the viewpoint of oxidative stress and mitochondrial dysfunction.
    Lee HT; Wu TH; Lin CS; Lee CS; Wei YH; Tsai CY; Chang DM
    Mitochondrion; 2016 Sep; 30():1-7. PubMed ID: 27235747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox Activation of Mitochondrial DAMPs and the Metabolic Consequences for Development of Autoimmunity.
    Koenig A; Buskiewicz-Koenig IA
    Antioxid Redox Signal; 2022 Mar; 36(7-9):441-461. PubMed ID: 35352943
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA.
    Becker Y; Marcoux G; Allaeys I; Julien AS; Loignon RC; Benk-Fortin H; Rollet-Labelle E; Rauch J; Fortin PR; Boilard E
    Front Immunol; 2019; 10():1026. PubMed ID: 31134086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling abnormalities in systemic lupus erythematosus as potential drug targets.
    Fernandez D; Bonilla E; Phillips P; Perl A
    Endocr Metab Immune Disord Drug Targets; 2006 Dec; 6(4):305-11. PubMed ID: 17214576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the innate and adaptive immune responses in the pathogenesis of systemic lupus erythematosus.
    Bolouri N; Akhtari M; Farhadi E; Mansouri R; Faezi ST; Jamshidi A; Mahmoudi M
    Inflamm Res; 2022 Jun; 71(5-6):537-554. PubMed ID: 35298669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor activation in the pathogenesis of systemic lupus erythematosus.
    Means TK; Luster AD
    Ann N Y Acad Sci; 2005 Dec; 1062():242-51. PubMed ID: 16461805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in mechanisms of systemic lupus erythematosus.
    Dema B; Charles N
    Discov Med; 2014 May; 17(95):247-55. PubMed ID: 24882716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial bioenergetic changes in systemic lupus erythematosus immune cell subsets: Contributions to pathogenesis and clinical applications.
    Yennemadi AS; Keane J; Leisching G
    Lupus; 2023 Apr; 32(5):603-611. PubMed ID: 36914582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of innate immunity in the induction of autoimmunity.
    Pisetsky DS
    Autoimmun Rev; 2008 Oct; 8(1):69-72. PubMed ID: 18708168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I interferons inhibition of inflammatory T helper cell responses in systemic lupus erythematosus.
    Mangini AJ; Lafyatis R; Van Seventer JM
    Ann N Y Acad Sci; 2007 Jun; 1108():11-23. PubMed ID: 17893966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus.
    Wong CK; Wong PT; Tam LS; Li EK; Chen DP; Lam CW
    Clin Exp Immunol; 2010 Jan; 159(1):11-22. PubMed ID: 19843090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.